BBGAT Celebrates First Mobile Cell Therapy Collection

November 05, 2025

BBG Advanced Therapies (BBGAT), a subsidiary of BioBridge Global, recently celebrated the first donation on its world-first mobile leukapheresis center.

The center collects immune cells from donors or patients to support the development of personalized treatments for blood cancers, solid tumors, autoimmune disorders and other conditions. It features two collection stations and a testing lab.

BioBridge Global hopes the mobile center will bring lifesaving therapies to areas that previously required travel to major academic centers.